SynBioBeta Speaker
Ariel Blumovich
CEO
YDLabs
May 2026, SynBioBeta
Speaker
Ariel Blumovich is the Founder & CEO of YDLabs, an Agritech & Foodtech fermentation CDMO headquartered in Israel, purpose-built to bridge the gap between synthetic biology innovation and commercial-scale manufacturing. With over 20 years of experience across biopharma and biotech, Ariel has held senior business development, strategy and manufacturing roles at Teva Pharmaceuticals, Sanofi, Samsung Biologics, and Enzymotec, giving him a rare combination of deep scientific industry knowledge and global commercial acumen spanning Israel, South Korea, and the United States.Ariel founded YDLabs to address a critical bottleneck in the Agri/Food-tech sector: the absence of a structured, reliable manufacturing pathway between early fermentation discovery and market-ready scale. Through an integrated infrastructure spanning 80L to 25,000L fermenters and full downstream processing, YDLabs offers clients a step-by-step scale-up pathway for biopesticides, biofertilizers, biostimulants, and industrial biotech, on a fee-for-service, no-equity model that keeps client IP fully protected.Ariel holds an MBA from Dartmouth's Tuck School of Business and a B.Sc. in Mechanical Engineering from the Technion.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.